Joar Austad

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet^®/Daivobet^®/Taclonex^®) in the treatment of psoriasis vulgaris

Knud Kragballe, Joar Austad, Larry D. Barnes et al. · British Journal of Dermatology · 2006 · 138 citations

Pharmacy, Dermatology, Pharmacotherapy +9

A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial

Gregor B. E. Jemec, Cecilia Ganslandt, Jean‐Paul Ortonne et al. · Journal of the American Academy of Dermatology · 2008 · 100 citations

Pharmacy, Dermatology, Pharmacotherapy +5

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

Knud Kragballe, Joar Austad, L. Barnes et al. · Dermatology · 2006 · 74 citations

Pharmacy, Dermatology, Pharmacotherapy +10

Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter <scp>STEPI</scp>n study

Lars Iversen, Liv Eidsmo, Joar Austad et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 53 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Short-wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands

NJ. Mørk, Joar Austad · Acta Dermato Venereologica · 1983 · 44 citations · Full text

Life Sciences, Dermatology, Allergy +9